messag updat estim dplo
neutral rate pt dplo neutral rate pt sell rate
pt neutral rate pt remain unchang
dplo neutral tweak revenue/adjust ebitda
estim
 previous updat estim reflect manag
commentari earn call regard cadenc perform
year forecast adjust ebitda flat q/q
neutral tweak revenue/adjust ebitda
estim
previous introduc revenue/adjust ebitda estim
updat estim incorpor compani recent quarterli result forward
sell tweak revenue/adjust ebitda estim
previous introduc revenue/adjust ebitda estim
updat estim incorpor compani recent quarterli result forward
neutral tweak revenue/adjust ebitda
estim
 previous updat
estim incorpor compani recent quarterli result forward look
page analyst certif import disclosur
valuat risk
dplo maintain price target base ebitda repres signific discount
compani histor averag think warrant given structur concern around busi given
price target impli potenti upsid current level believ neutral rate appropri primari risk downsid
continu structur pressur specialti pbm busi well potenti lower expect brand inflat
primari risk upsid faster expect recoveri recent custom loss favor reimburs
maintain price target base ebitda vs previou target multipl
higher multipl closer compani histor averag reflect greater confid dental end-market
rise valuat dental peer main risk upsid acceler consum demand better expect
impact compani restructur initi main risk downsid potenti neg impact price
growth dental servic organ dso potenti on-line player take market share
maintain price target base ebitda vs previou multipl
repres signific discount compani histor averag believ warrant given greater
structur pressur face busi slightli higher multipl vs previou target multipl reflect rise valuat
across suppli chain industri trade main risk upsid acceler allevi reimburs
pressur favor gener price
maintain price target base ebitda repres signific discount
histor averag believ warrant given structur concern retail pharmaci space
slightli lower previou target multipl reflect greater level structur pressur share main risk
upsid acceler allevi reimburs pressur favor gener price main risk downsid
intensifi competit environ drive lower reimburs rate potenti on-line player take market share
page analyst certif import disclosur
issu research report guggenheim secur llc guggenheim secur research analyst whose name appear report
herebi certifi view express report accur reflect research analyst person view subject
secur issuer discuss herein ii part research analyst compens directli indirectli relat specif
recommend view express research analyst
research analyst research associ receiv compens base upon variou factor includ qualiti research investor client
feedback guggenheim secur llc overal revenu includ invest bank revenu
guggenheim secur llc affili expect receiv intend seek compens invest bank servic rite aid
corpor inc diplomat pharmaci inc next month
pleas refer websit company-specif disclosur referenc report http //guggenheimsecur bluematrix com/sellside/
disclosur action disclosur inform also avail complianc madison avenu new york ny
rate price target histori rite aid corpor
rate price target histori inc
creat bluematrix
creat bluematrix
page analyst certif import disclosur
rate price target histori walgreen boot allianc
rate price target histori diplomat pharmaci inc dplo
creat bluematrix
creat bluematrix
buy describ stock expect provid total return price appreci plu yield within period
neutral describ stock expect provid total return price appreci plu yield plu minu within
sell describ stock expect provid total neg return price appreci plu yield within period
nr invest rate price target temporarili suspend suspens complianc applic regul and/or
cs coverag suspend guggenheim secur llc suspend coverag compani
nc cover guggenheim secur llc cover compani
monitor describ stock whose compani fundament financi monitor financi project opinion
invest merit compani provid
review ur follow releas signific news compani rate temporarili place review suffici
inform obtain assess analyst
guggenheim secur llc methodolog assign rate may includ follow market capit matur growth/valu volatil
expect total return next month price target base sever methodolog may includ restrict analys
market risk growth rate revenu stream discount cash flow dcf ebitda ep cash flow cf free cash flow ev/ebitda price-to-earnings pe/growth
price-to-cf p/fcf premium discount /averag group ev/ebitda premium discount /averag group price-to-earnings sum part net asset valu dividend return
return equiti roe next month
price target assign buy- sell-rat stock price target neutral-r stock provid discret analyst
page analyst certif import disclosur
